{
  "report_rows": [
    {
      "kpi": "Q2 2026 Revenue",
      "prediction": "BEAT",
      "answer": "pred ~$1.215B vs. cons $1.20B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 EPS",
      "prediction": "BEAT",
      "answer": "pred ~$4.05 vs. cons $3.95",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "CAG Diagnostics Recurring Organic Revenue Growth (Q2)",
      "prediction": "BEAT",
      "answer": "pred ~10.5% vs. cons ~9.5% (implied guide midpoint)",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 EPS Guidance",
      "prediction": "BETTER",
      "answer": "guide ~$14.80-$15.10 vs. cons ~$14.75 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 Organic Revenue Growth Guidance",
      "prediction": "BETTER",
      "answer": "guide ~8.7%-9.2% vs. cons ~8.7% midpoint (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 CAG Diagnostics Recurring Revenue Growth Guidance",
      "prediction": "BETTER",
      "answer": "guide ~9.5%-10.2% vs. cons ~9.7% midpoint (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 Operating Margin (comparable expansion)",
      "prediction": "UNCHANGED",
      "answer": "guide ~33.9%-34.3% vs. cons ~34.1% (Q2 2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "InVue Dx Full-Year Placement Target",
      "prediction": "UNCHANGED",
      "answer": "guide ~5,500 units vs. cons ~5,500 units (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 5.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 2.0,
  "day5_path": "FADE",
  "day5_rationale": "A likely Q2 beat-and-modest-raise triggers an initial relief pop given the stock's ~21% de-rating off highs and low Zacks ESP bar, but the implied H2 CAG Diagnostics recurring growth deceleration (H1 running ~10%+ vs. FY midpoint ~8.7-9.7%) and the flagged Q2 margin-expansion step-down (spend timing) give analysts room to trim out-quarter/FY27 estimates once they model the tougher comps, capping and partially fading the initial move over the following days.",
  "day5_confidence": "MEDIUM"
}